Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
HUGO Series 🌟
HUGO-GT™ (Humanized Genomic Ortholog)
HUGO-Ab™ (Humanized Genomic Ortholog for Antibody)
MouseAtlas Model Library
Flash Sales
Research Models
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
Cell Line Models
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Services
Preclinical Efficacy
Neuroscience
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
Genetically Engineered Animals
Knockout Mice
Transgenic Mice
Knockin Mice
Knockout Rats
Knockin Rats
Transgenic Rats
Model Generation Techniques
Turboknockout® Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Breeding & Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Modalities
Gene Therapy
AI-Powered AAV Discovery
Oligonucleotide Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
About Us
Corporate Overview
Facility Overview
Animal Health & Welfare
Health Reports
Our Partners
Careers
Contact Us
Login
Live Webinar
De-Risking Drug Development through Predictive Human Disease Models
Advanced translational research platforms are essential for bridging the gap between discovery and clinical success—yet many programs still fail due to the limited human relevance of traditional preclinical models.
In this webinar, we will present Cyagen’s comprehensive disease modeling ecosystem, featuring advanced cell-based assays, patient-relevant iPSC models, and humanized rodent platforms. Through practical examples and case studies, you will learn how this integrated, predictive approach generates actionable insights to de-risk drug development and accelerate the transition from discovery to the clinic.
DATE
February 27, 2026 | 16:00 PM (CET)
LOCATION
Online|Zoom
February 27, 2026 | 16:00 PM (CET)
Register Now
Ideas to lND - Your Pathway to Discovery
Empowering Preclinical Innovation
Unlock the full potential of your preclinical research with Cyagen Biosciences. Our integrated solutions span from custom cell and animal model development through preclinical experiments, ensuring every phase of your project is expertly handled. Discover how we can help transform your innovative ideas into actionable outcomes and help translate your research discoveries into INDs.
OK to Switch
Receive Up to 15 Free NKG Mice for Trial
Explore
Innovative Solutions & Trusted Products
Genetically Engineered Animals
Cyagen provides knockout, knockin, and transgenic models with high genetic precision to support research in genetics, pharmacology, and disease modeling.
Comprehensive Research Models
Our humanized, knockout, and disease-specific mice closely mimic human conditions, empowering your preclinical studies from rare diseases to oncology.
Custom Cell Lines
Cyagen delivers custom iPSC, knockout, and knockin cell lines for genetic studies, drug screening, and therapeutic development.
Virus Packaging Solutions
We offer AAV, lentivirus, and adenovirus packaging for gene therapy, vaccine R&D, and gene editing applications.
Antibody Therapy CRO Services
Cyagen accelerates antibody drug discovery with fully human antibody mice and AI-powered screening, supporting you from discovery to validation.
Animal Quality
We uphold the highest standards in animal welfare and qualty in our AAALAC-accredited faciities, ensuring ethical research practices.
Special Promotions & Discounts
See All Promotions
special offer
Flash Drop — Ready-to-Ship KO/CKO Mice
Unlock fast, budget-friendly access to KO/CKO mouse lines from Cyagen’s MouseAtlas.we will release exclusive flash deals on selected knockout and conditional knockout strains in real-time– helping you launch or expand your in vivo studies without long lead times or high upfront costs.
Explore
Free Trial
OK to Switch - Introducing the Locally Bred NKG Mice
Cyagen is inviting researchers to experience the benefits of our NKG mice breed in the US. This "OK to Switch" offer is designed to help you easily transition from your current models with zero risk and gap.
Explore
Special Offer
Cell Line Project Special Offer
Get guaranteed, publication-ready cell lines without the endless troubleshooting. For a limited time, let our experts deliver your custom model for 50% less
Explore
Your Partners in Preclinical Progress
Your Partners in Preclinical Progress
At Cyagen, we pioneer advancements in life sciences, transforming research into real-world health solutions.
19
Years of Genetic Innovation
7,000
Global Bioscience Partners
50,000
Mouse & Rat Models Delivered
10,925
SCI Journal Citations
250,000
SPF Animals in AAALAC-Accredited Facilities
Citation Database
Molecular Therapy: Methods & Clinical Development, March, 2025
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
【Other】
Gut, February, 2025
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
【Other】
Cell Death & Disease, February, 2025
Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage
【Other】
Molecular Therapy, February, 2025
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer
【Other】
Resource Library
BLOG & INSIGHTS
More Insights
JPM 2026 Insights
JPM 2026 Insights
JPM 2026 Insights by Cyagen: AI Transformation, Globalization 2.0, and Emerging Innovations in Core Modalities from Next-Gen ADCs to Degrader-Antibody Conjugates (DACs)
February 05, 2026
Schedule Meeting
UPCOMING EVENT
More
NextGen Biomed 2026
NextGen Biomed 2026
Cyagen will attend NextGen Biomed 2026 on March 24–25 in London, UK. Our expert, Ivan Gladwyn-Ng, will hosting presentations on antibody, drug development strategies and showcase Cyagen’s advanced mouse models and integrated preclinical research solutions. We look forward to connecting with you!
Schedule Meeting
WEBINAR
More
De-Risking Drug Development through Predictive Human Disease Models
De-Risking Drug Development through Predictive Human Disease Models
Discover how Cyagen’s integrated in vitro and in vivo platforms (iPSC & humanized mice) de-risk drug development and accelerate translational success.
Schedule Meeting
FEATURED NEWS
Taconic and Cyagen Collaborate to Streamline Access to Preclinical Mouse and Rat Models
August 04, 2025
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Models
HUGO-Ab™ (Humanized Genomic Ortholog for Antibody)HUGO-GT™ (Humanized Genomic Ortholog)MouseAtlas Model LibraryResearch Models
Services
NeuroscienceOphthalmologyOncologyMetabolic & Cardiovascular DiseasesAutoimmune & Inflammatory
About Us
Corporate OverviewFacility OverviewAnimal Health & WelfareHealth ReportsOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research